Dr. Bronner’s, a well-known liquid soap company that has evolved into a household name, is making waves in the industry. A new campaign is coming that promotes the benefits of psychedelics.
The brand is famous for its bottles with tiny-font labels that line the shelves of supermarkets across the country. Often, it lists the ingredients of the product and preaches peace and love, and now–for a limited time–special editions of the famous soap will include the pros of mind-altering drugs.
“Let’s face it, the world would be a far better place if more people experienced psychedelic medicines,” said David Bronner, one of the company’s top executives and grandson of the company’s founder.
Keeping to his word, the company’s employee health care coverage became one of the first in the United States to cover ketamine therapy in January. More than that, according to corporate documents, Dr. Bronner’s Magic Soaps has donated more than $23 million to drug advocacy and research organization since 2015.
Ketamine treatment for depression isn’t new by any means, but Dr. Bronner’s is one of the first major companies to normalize its use for employees who struggle with their mental health.
Other companies, like Open Society Foundations, have steered quietly towards drug policy changes, but Dr. Bronner’s is rare in their boisterous tone, speaking to news sources like The New York Times about psychedelics and ketamine therapy for employees.
Moves are being made around the country for drug reform, with Washington State lawmakers introducing the Psilocybin Wellness and Opportunity Act and Maryland attempting to pass a pro-psychedelics bill that would create a Post-Traumatic Stress Disorder Alternative Therapies Fund, but its well-known companies like Dr. Bronner’s that help move the cause forward in the eyes of the public.
Kaeli Swaggerty holds a B.A. in English from the University of Tennessee, Knoxville. Connect with her about bringing awareness to mental health issues on LinkedIn.
Jacobs, Andrew. “Dr. Bronner’s, The Soap Company, Dips into Psychedelics.” The New York Times, The New York Times, 28 Feb. 2022, https://www.nytimes.com/2022/02/28/health/ketamine-bronner-bros.html.